Other Streetwise Reports
The Gold Report The Energy Report The Life Sciences Report The Metals ReportMore Experts
"BTI's Transcend platform is a huge financial incentive to the owner of the therapy because it could greatly extend the drug's exclusivity." (5/16/13) biOasis Technologies Inc. - The Life Sciences Report Interview with William Gregozeski More >
"ATHX is a neat little company that has a great management team and deep science bench." (5/10/13) Athersys Inc. - The Life Sciences Report Interview with Jason Kolbert More >
"MSLP was growing very fast, and it had significant events that made it possible for us to raise $12M for it." (4/25/13) MusclePharm Corp. - The Life Sciences Report Interview with Richard Huebner More >
"What's particularly exciting about VNRX is that it believes its technology is able to identify targeted cancers in stage 1 and stage 2." (4/25/13) VolitionRx Ltd. - The Life Sciences Report Interview with Dick Huebner More >
"ATHX's partnership with Pfizer Inc. puts it in a remarkable position." (4/11/13) Athersys Inc. - The Life Sciences Report Interview with Steve Brozak More >
Sector Experts
Subscribe to
Streetwise Reports
Companies Commented On
- American Manganese Inc.
- American Vanadium Corp.
- Americas Bullion Royalty Corp., formerly Golden Predator Corp.
- Antioquia Gold Inc.
- Apella Resources Inc.
- B2Gold Corp.
- Bellhaven Copper & Gold Inc.
- Endeavour Silver Corp.
- European Uranium Resources Ltd.
- EVRAZ Group S.A.
- Frontier Rare Earths Ltd.
- Galore Resources Inc.
- Galway Resources Ltd.
- Geologix Explorations Inc.
- GMV Minerals Inc.
- Gold Standard Ventures Corp.
- Goldcorp Inc.
- Grande Portage Resources Ltd.
- Great Western Minerals Group Ltd.
- Guyana Goldfields Inc.
- International Enexco Ltd.
- Largo Resources Ltd.
- Lynas Corp.
- Macarthur Minerals
- Midway Energy Ltd.
- Midway Gold Corp.
- Molycorp Inc.
- Neuralstem Inc.
- Newstrike Capital Inc.
- Northern Graphite Corporation
- OPKO Health Inc.
- Passport Potash Inc.
- Pershing Gold Corp.
- Quaterra Resources Inc.
- Redhawk Resources Inc.
- Revett Minerals Inc.
- Sandspring Resources Ltd.
- Southern Silver Exploration Corp.
- Stans Energy Corp.
- Sulliden Gold Corp.
- Talison Lithium Ltd.
- Terraco Gold Corp.
- Timmins Gold Corp.
- Ucore Rare Metals Inc.
- Uranium Energy Corp.
- Xstrata Plc
Michael Berry
Morning Notes
http://discoveryinvesting.com/
From 1982–1990, Michael Berry served as a professor of investments at the Colgate Darden Graduate School of Business Administration at the University of Virginia, during which time he published a book, Managing Investments: A Case Approach. He has managed small- and mid-cap value portfolios for Heartland Advisors and Kemper Scudder. His publication, Morning Notes, analyzes emerging geopolitical, technological and economic trends. He travels the world with his son, Chris, looking for discovery opportunities for his readers.
Recent Interviews
Gold Has Stood the Test of Time: Michael and Chris Berry (6/13/13) The synergy of temperament and intellect has fostered much success for the father-son team of Michael Berry, editor of Morning Notes, and Chris Berry, founder of House Mountain Partners LLC. In this Father's Day interview, the Berrys reveal what they've learned from each other's investment strategies over the years and why they are still bullish on gold.
Transformative Energy Technologies: Michael and Chris Berry (6/13/13) The synergy of temperament and intellect has fostered much success for the father-son team of Michael Berry, editor of Morning Notes, and Chris Berry, founder of House Mountain Partners LLC. In this Father's Day interview with The Energy Report, the Berrys reveal what they've learned from each other's investment strategies over the years, and mull energy metals and emerging green technologies that could be "compelling investment opportunities." They also reveal that, for all the familial camaraderie, there are energy issues about which they strongly disagree.
Mike Berry's New Secret for Finding Winners—Optionality (2/27/13) You will not find it in the dictionary, but a company's "optionality"—the condition of having choices—signals its chances of success according to Dr. Michael Berry. In this Gold Report interview, Berry, the editor of Morning Notes and discoveryinvesting.com, talks about junior mining firms in Nevada and Mexico that display optionality and sustainability in a market stuck in the mire.
Recent Quotes
"IEC has the option to be valued on its uranium or on its copper or both." (2/27/13) International Enexco Ltd. - The Gold Report Interview with Michael Berry More >
"There is so much value that I would buy TEN stock and sit on it." (2/27/13) Terraco Gold Corp. - The Gold Report Interview with Michael Berry More >
"PGLC's Steve Alfers has done more deals in Nevada gold than anyone I know." (2/27/13) Pershing Gold Corp. - The Gold Report Interview with Michael Berry More >
"G is a great company with lots of cash flow." (2/27/13) Goldcorp Inc. - The Gold Report Interview with Michael Berry More >
"GSV is a tremendous buy; it has a district-scale system developing." (2/27/13) Gold Standard Ventures Corp. - The Gold Report Interview with Michael Berry More >
"I don't think people realize GIX has ~800 Mlb copper. That story needs to get out." (2/27/13) Geologix Explorations Inc. - The Gold Report Interview with Michael Berry More >
"PGLC's wealth creation program is a great success." (1/24/13) Pershing Gold Corp. - Michael Berry, Morning Notes More >
"Results of PGLC's fall drill program were excellent." (12/4/12) Pershing Gold Corp. - Michael Berry, Morning Notes More >
Notable Quotes
"CYTR's preclinical data for aldoxorubicin has been very supportive, and its phase 1b/2 trial has shown quite promising, albeit early stage, efficacy." (6/13/13) CytRx Corp. - The Life Sciences Report Interview with Michael Aikenhead More >
"ATHX is an exciting story and definitely a company to watch." (6/6/13) Athersys Inc. - The Life Sciences Report Interview with Christian Glennie More >
"NEO has been able to continue to grow the topline nicely and maintain margins of more than 45%." (5/30/13) NeoGenomics Laboratories - The Life Science Report with Kevin DeGeeter More >
"OPK's 4Kscore is approved in Europe and should be approved in the U.S. sometime in 2013." (5/30/13) OPKO Health Inc. - The Life Science Report with Kevin DeGeeter More >
"CTH is very early in the game with a very good and relatively derisked idea." (5/30/13) Cynapsus Therapeutics Inc. - The Life Science Report with Ori Hershkovitz More >
The Life Sciences Report